BioAge Labs, Inc.
BIOA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| R&D Expenses | $59,036 | $33,886 | $30,522 |
| G&A Expenses | $19,158 | $14,514 | $9,447 |
| SG&A Expenses | $19,158 | $14,514 | $9,447 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $78,194 | $48,400 | $39,969 |
| Operating Income | -$78,194 | -$48,400 | -$39,969 |
| % Margin | – | – | – |
| Other Income/Exp. Net | $7,085 | -$15,454 | $247 |
| Pre-Tax Income | -$71,109 | -$63,854 | -$39,722 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$71,109 | -$63,854 | -$39,722 |
| % Margin | – | – | – |
| EPS | -6.63 | -8.55 | -5.32 |
| % Growth | 22.5% | -60.7% | – |
| EPS Diluted | -6.63 | -8.55 | -5.32 |
| Weighted Avg Shares Out | 10,727 | 7,465 | 7,460 |
| Weighted Avg Shares Out Dil | 10,727 | 7,465 | 7,460 |
| Supplemental Information | – | – | – |
| Interest Income | $9,629 | $2,431 | $465 |
| Interest Expense | $2,367 | $7,794 | $241 |
| Depreciation & Amortization | $167 | $162 | $129 |
| EBITDA | -$68,575 | -$55,898 | -$39,352 |
| % Margin | – | – | – |